Cite
MLA Citation
JT Merrill et al.. “SAT0219 Efficacy and safety of atacicept in patients with high disease activity in a 24-week, randomized, placebo-controlled, phase iib study (ADDRESS II).” Annals of the rheumatic diseases, vol. 76, n.d., p. 856. http://access.bl.uk/ark:/81055/vdc_100135158761.0x000063